You are here

  • Home
  • Archive
  • Volume 69, Issue 3
  • Short-term use of clarithromycin in lower respiratory tract infections may increase long-term risk of cardiovascular mortality and morbidity

Article Text

Article menu
Download PDFPDF
Miscellanea
Journal club
Short-term use of clarithromycin in lower respiratory tract infections may increase long-term risk of cardiovascular mortality and morbidity
  1. Haider Al-Najjar
  1. Correspondence to Dr Haider Al-Najjar, SPR in Respiratory, Southmead Hospital, Southmead Road, Bristol BS10 5NB, UK; haidernajjar{at}hotmail.com

https://doi.org/10.1136/thoraxjnl-2013-204080

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Macrolides are commonly prescribed for chronic obstructive pulmonary disease (COPD) exacerbations and community-acquired pneumonia. The short-term cardiovascular effects, probably due to QT prolongation, are well documented and some studies have implicated macrolides with increased mortality in patients with pre-existing coronary disease.

    This study evaluated the association between clarithromycin use and cardiovascular events in patients treated for lower respiratory tract infections in a secondary analysis of two prospective …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.